205 related articles for article (PubMed ID: 26196061)
1. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
Jiang B; Pei D
J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
[TBL] [Abstract][Full Text] [Related]
2. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
Lian W; Jiang B; Qian Z; Pei D
J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
[TBL] [Abstract][Full Text] [Related]
3. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
Liu T; Liu Y; Kao HY; Pei D
J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
5. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
[TBL] [Abstract][Full Text] [Related]
7. Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1.
Bedewy W; Liao H; Abou-Taleb NA; Hammad SF; Nasr T; Pei D
Org Biomol Chem; 2017 May; 15(21):4540-4543. PubMed ID: 28517007
[TBL] [Abstract][Full Text] [Related]
8. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
[TBL] [Abstract][Full Text] [Related]
9. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
10. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
[TBL] [Abstract][Full Text] [Related]
11. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
13. Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3.
Albert AL; Lavoie SB; Vincent M
BMC Cell Biol; 2004 Jun; 5():22. PubMed ID: 15171797
[TBL] [Abstract][Full Text] [Related]
14. The Peptidyl-Prolyl
Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
[TBL] [Abstract][Full Text] [Related]
15. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
17. The prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity.
Jalouli M; Déry MA; Lafleur VN; Lamalice L; Zhou XZ; Lu KP; Richard DE
Cell Signal; 2014 Aug; 26(8):1649-56. PubMed ID: 24726894
[TBL] [Abstract][Full Text] [Related]
18. Substrate-based design of reversible Pin1 inhibitors.
Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
[TBL] [Abstract][Full Text] [Related]
20. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
Siepe D; Jentsch S
Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
